Dethlefs-Canto J, Baeza-Vallejos S, Ormeño-Sepúlveda D, Bustos-Ponce A
Altamirano Subida Carvallo 211 Valparaíso, Chile
Med Oral Patol Oral Cir Bucal. 2025 Jul 1;30(4):e561-e567. doi: 10.4317/medoral.27093.
Down Syndrome (DS), caused by an extra chromosome 21, has a prevalence of 24.7 per 10,000 live births in Chile, the highest in Latin America. Individuals with DS commonly present orofacial and dental anomalies, complicating oral health management. Many depend on removable prostheses, which represent challenges in hygiene, handling, and adaptation. Dental implants are a promising alternative, offering improved stability and functionality. However, successful rehabilitation requires addressing specific anatomical, physiological, and behavioral considerations. This scoping review compiles evidence-based strategies to guide implant treatment in this population.
Registered on the Open Science Framework (https://osf.io/bstwk/), this review followed the PRISMA-ScR protocol, addressing the question: "Which are the management strategies and survival rates of dental implants in patients with Down Syndrome?" Searches were conducted in Pubmed/MEDLINE, Scopus, Science Direct, Web of Science, and Ebsco databases.
Of 92 studies identified, 7 met inclusion criteria, encompassing 179 implants in DS patients. Anesthesia type varied based on patient cooperation and procedure complexity: general anesthesia for uncooperative patients, local anesthesia for compliant individuals, and sedation for intermediate cases. Delayed loading (3-12 months) yielded better outcomes than immediate loading. Overdentures with locator or bar systems were effective and easier to maintain, while screw-retained fixed prostheses provided stability but required strict hygiene adherence. Clinical success rates varied, with higher success in simple cases and higher failure rates in studies involving multiple implants.
Dental implants, combined with structured behavioral management, improve oral rehabilitation outcomes in DS patients. While sedation or general anesthesia may be required, associated risks must be carefully managed. Delayed implant loading is recommended to minimize osseointegration failures. An interdisciplinary approach, including material selection, caregiver education, and long-term maintenance, is essential for successful, individualized outcomes.
唐氏综合征(DS)由额外的21号染色体引起,在智利每10000例活产中的患病率为24.7,是拉丁美洲最高的。唐氏综合征患者通常存在口面部和牙齿异常,使口腔健康管理复杂化。许多患者依赖可摘义齿,这在卫生、处理和适应方面带来挑战。牙种植体是一种有前景的替代方案,具有更好的稳定性和功能性。然而,成功的修复需要考虑特定的解剖、生理和行为因素。本综述汇编了基于证据的策略,以指导该人群的种植治疗。
本综述在开放科学框架(https://osf.io/bstwk/)上注册,遵循PRISMA-ScR方案,解决以下问题:“唐氏综合征患者牙种植体的管理策略和生存率是多少?”在PubMed/MEDLINE、Scopus、Science Direct、Web of Science和Ebsco数据库中进行检索。
在识别出的92项研究中,7项符合纳入标准,涵盖179例唐氏综合征患者的种植体。麻醉类型根据患者的合作程度和手术复杂性而有所不同:不合作患者采用全身麻醉,配合良好的患者采用局部麻醉,中等情况采用镇静。延迟加载(3 - 12个月)比即刻加载产生更好的效果。带有定位器或杆系统的覆盖义齿有效且易于维护,而螺丝固位的固定义齿提供稳定性,但需要严格遵守卫生要求。临床成功率各不相同,简单病例的成功率较高,涉及多个种植体的研究中失败率较高。
牙种植体结合结构化行为管理可改善唐氏综合征患者的口腔修复效果。虽然可能需要镇静或全身麻醉,但必须谨慎管理相关风险。建议延迟种植体加载以尽量减少骨结合失败。包括材料选择、护理人员教育和长期维护在内的多学科方法对于成功实现个体化治疗结果至关重要。